Search results
Results from the Health.Zone Content Network
The COVID-19 vaccination program in the Philippines was a mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a ...
An International Certificate of Vaccination or Revaccination Against Yellow Fever, issued in the Soviet Union in 1985. The International Certificate of Inoculation and Vaccination was established by the International Sanitary Convention for Aerial Navigation (1933) in The Hague, which came into force on 1 August 1935 and was amended in 1944. [3]
In February 2021, Novavax partnered with Takeda to manufacture the vaccine in Japan, where its COVID‑19 vaccine candidate is known as TAK-019. [54] Novavax signed an agreement with Serum Institute of India for mass scale production for developing and low-income countries. [55]
Pfizer–BioNTech COVID-19 vaccine A vial of the Pfizer–BioNTech COVID‑19 vaccine for the U.S. market Vaccine description Target SARS-CoV-2 Vaccine type mRNA Clinical data Trade names Comirnaty Other names BNT162b2, COVID-19 mRNA vaccine (nucleoside-modified), COVID-19 Vaccine (mRNA) AHFS / Drugs.com Monograph MedlinePlus a621003 License data EU EMA: by INN US DailyMed: Pfizer-BioNTech ...
The coronavirus disease 2019 (COVID-19) vaccine is important for preventing serious illness and death due to COVID-19. So far, 81.4% of people in the United States have received at least one dose ...
A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date (s) one has received the shot (s) and the brand of vaccine one has received, sometimes including the lot number. The card also contains information identifying the recipient and the location where the shot was given.
A study on the effectiveness of a first dose of the Pfizer–BioNTech or Oxford–AstraZeneca COVID-19 vaccines against COVID-19 related hospitalisation in Scotland was based on a national prospective cohort study of 5.4 million people. Between 8 December 2020 and 15 February 2021, 1,137,775 participants were vaccinated in the study, 490,000 of ...
On 7 May 2021, the World Health Organization added the vaccine to the list of vaccines authorized for emergency use for COVID-19 Vaccines Global Access (COVAX). In May 2021, Zambia approved use of the vaccine. In June 2021, Philippines approved the BIBP vaccine for emergency use.